Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced disease for clinicians who treat patients with prostate cancer. The portions of the guidelines included herein focus on the roles of germline and somatic genetic testing, risk stratification with nomograms and tumor multigene molecular testing, androgen deprivation therapy, secondary hormonal therapy, chemotherapy, and immunotherapy in patients with prostate cancer.

Related collections

Author and article information

Journal

Title: Journal of the National Comprehensive Cancer Network

Publisher: Harborside Press, LLC

ISSN (Print): 1540-1405

ISSN (Electronic): 1540-1413

Publication date Created: May 2019

Publication date (Print): May 2019

Volume: 17

Issue: 5

Pages: 479-505

Affiliations

[1 ]1Roswell Park Comprehensive Cancer Center;

[2 ]2The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

[3 ]3Duke Cancer Institute;

[4 ]4Dana-Farber/Brigham and Women’s Cancer Center;

[5 ]5Mayo Clinic Cancer Center;

[6 ]6City of Hope National Cancer Center;

[7 ]7Memorial Sloan Kettering Cancer Center;

[8 ]8Fred & Pamela Buffett Cancer Center;

[9 ]9Prostate Health Education Network (PHEN);

[10 ]10Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

[11 ]11Fox Chase Cancer Center;

[12 ]12Yale Cancer Center/Smilow Cancer Hospital;

[13 ]13Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

[14 ]14UC San Diego Moores Cancer Center;

[15 ]15University of Wisconsin Carbone Cancer Center;

[16 ]16Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

[17 ]17University of Alabama at Birmingham Comprehensive Cancer Center;

[18 ]18Vanderbilt-Ingram Cancer Center;

[19 ]19Moffitt Cancer Center;

[20 ]20University of Colorado Cancer Center;

[21 ]21St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center;

[22 ]22UCSF Helen Diller Family Comprehensive Cancer Center;

[23 ]23Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

[24 ]24The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

[25 ]25University of Michigan Rogel Cancer Center;

[26 ]26Stanford Cancer Institute;

[27 ]27Huntsman Cancer Institute at the University of Utah; and

[28 ]28National Comprehensive Cancer Network

Article

DOI: 10.6004/jnccn.2019.0023

PubMed ID: 31085757

SO-VID: 3f86c54f-88a0-420e-9e8a-39941519ddaa

History

Data availability:

Comments

Comment on this article

scite_

Cited by 418

See all cited by

- Version 1